BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29180457)

  • 1. Antihypertensive Treatment With β-Blockade in Patients With Asymptomatic Aortic Stenosis and Association With Cardiovascular Events.
    Bang CN; Greve AM; Rossebø AB; Ray S; Egstrup K; Boman K; Nienaber C; Okin PM; Devereux RB; Wachtell K
    J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29180457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing Optimal Blood Pressure in Patients With Asymptomatic Aortic Valve Stenosis: The Simvastatin Ezetimibe in Aortic Stenosis Study (SEAS).
    Nielsen OW; Sajadieh A; Sabbah M; Greve AM; Olsen MH; Boman K; Nienaber CA; Kesäniemi YA; Pedersen TR; Willenheimer R; Wachtell K
    Circulation; 2016 Aug; 134(6):455-68. PubMed ID: 27486164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left atrial size and function as predictors of new-onset of atrial fibrillation in patients with asymptomatic aortic stenosis: the simvastatin and ezetimibe in aortic stenosis study.
    Bang CN; Dalsgaard M; Greve AM; Køber L; Gohlke-Baerwolf C; Ray S; Rossebø AB; Egstrup K; Wachtell K
    Int J Cardiol; 2013 Oct; 168(3):2322-7. PubMed ID: 23416018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher Acceleration/Ejection Time Ratio Predicts Impaired Outcome in Aortic Valve Stenosis.
    Einarsen E; Cramariuc D; Bahlmann E; Midtbo H; Chambers JB; Gerdts E
    Circ Cardiovasc Imaging; 2021 Jan; 14(1):e011467. PubMed ID: 33461302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of Left Ventricular Mass to Prognosis in Initially Asymptomatic Mild to Moderate Aortic Valve Stenosis.
    Gerdts E; Rossebø AB; Pedersen TR; Cioffi G; Lønnebakken MT; Cramariuc D; Rogge BP; Devereux RB
    Circ Cardiovasc Imaging; 2015 Nov; 8(11):e003644; discussion e003644. PubMed ID: 26489804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of Lipid-Lowering Therapy to Need for Aortic Valve Replacement in Patients With Asymptomatic Mild to Moderate Aortic Stenosis.
    Greve AM; Bang CN; Boman K; Egstrup K; Kesäniemi YA; Ray S; Pedersen TR; Wachtell K
    Am J Cardiol; 2019 Dec; 124(11):1736-1740. PubMed ID: 31586530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of stroke volume on cardiovascular risk during progression of aortic valve stenosis.
    Lønnebakken MT; De Simone G; Saeed S; Boman K; Rossebø AB; Bahlmann E; Gohlke-Bärwolf C; Gerdts E
    Heart; 2017 Sep; 103(18):1443-1448. PubMed ID: 28455295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resting heart rate and risk of adverse cardiovascular outcomes in asymptomatic aortic stenosis: the SEAS study.
    Greve AM; Bang CN; Berg RM; Egstrup K; Rossebø AB; Boman K; Nienaber CA; Ray S; Gohlke-Baerwolf C; Nielsen OW; Okin PM; Devereux RB; Køber L; Wachtell K
    Int J Cardiol; 2015 Feb; 180():122-8. PubMed ID: 25438232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension in aortic stenosis: implications for left ventricular structure and cardiovascular events.
    Rieck ÅE; Cramariuc D; Boman K; Gohlke-Bärwolf C; Staal EM; Lønnebakken MT; Rossebø AB; Gerdts E
    Hypertension; 2012 Jul; 60(1):90-7. PubMed ID: 22647889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke in patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Greve AM; Dalsgaard M; Bang CN; Egstrup K; Ray S; Boman K; Rossebø AB; Gohlke-Baerwolf C; Devereux RB; Køber L; Wachtell K
    Stroke; 2014 Jul; 45(7):1939-46. PubMed ID: 24903982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of the electrocardiogram in predicting cardiovascular mortality in asymptomatic adults with aortic stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis Study).
    Greve AM; Dalsgaard M; Bang CN; Egstrup K; Rossebø AB; Boman K; Cramariuc D; Nienaber CA; Ray S; Gohlke-Baerwolf C; Okin PM; Devereux RB; Køber L; Wachtell K
    Am J Cardiol; 2014 Sep; 114(5):751-6. PubMed ID: 25048345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.
    Rossebø AB; Pedersen TR; Boman K; Brudi P; Chambers JB; Egstrup K; Gerdts E; Gohlke-Bärwolf C; Holme I; Kesäniemi YA; Malbecq W; Nienaber CA; Ray S; Skjaerpe T; Wachtell K; Willenheimer R;
    N Engl J Med; 2008 Sep; 359(13):1343-56. PubMed ID: 18765433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis.
    Bang CN; Greve AM; Køber L; Rossebø AB; Ray S; Boman K; Nienaber CA; Devereux RB; Wachtell K
    Int J Cardiol; 2014 Aug; 175(3):492-8. PubMed ID: 25012498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower Transaortic Flow Rate Is Associated With Increased Mortality in Aortic Valve Stenosis.
    Saeed S; Senior R; Chahal NS; Lønnebakken MT; Chambers JB; Bahlmann E; Gerdts E
    JACC Cardiovasc Imaging; 2017 Aug; 10(8):912-920. PubMed ID: 28797414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of estimated left atrial volume on prognosis in patients with asymptomatic mild to moderate aortic valve stenosis.
    Losi MA; Mancusi C; Midtbø H; Saeed S; de Simone G; Gerdts E
    Int J Cardiol; 2019 Dec; 297():121-125. PubMed ID: 31604654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global left ventricular load in asymptomatic aortic stenosis: covariates and prognostic implication (the SEAS trial).
    Rieck AE; Gerdts E; Lønnebakken MT; Bahlmann E; Cioffi G; Gohlke-Bärwolf C; Ray S; Cramariuc D
    Cardiovasc Ultrasound; 2012 Nov; 10():43. PubMed ID: 23126645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lipid lowering on new-onset atrial fibrillation in patients with asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study.
    Bang CN; Greve AM; Boman K; Egstrup K; Gohlke-Baerwolf C; Køber L; Nienaber CA; Ray S; Rossebø AB; Wachtell K
    Am Heart J; 2012 Apr; 163(4):690-6. PubMed ID: 22520536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Greve AM; Boman K; Gohlke-Baerwolf C; Kesäniemi YA; Nienaber C; Ray S; Egstrup K; Rossebø AB; Devereux RB; Køber L; Willenheimer R; Wachtell K
    Circulation; 2012 Jan; 125(2):346-53. PubMed ID: 22147903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of obesity on left ventricular mass and systolic function in patients with asymptomatic aortic stenosis (a Simvastatin Ezetimibe in Aortic Stenosis [SEAS] substudy).
    Lund BP; Gohlke-Bärwolf C; Cramariuc D; Rossebø AB; Rieck AE; Gerdts E
    Am J Cardiol; 2010 May; 105(10):1456-60. PubMed ID: 20451694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in cardiovascular outcome during progression of aortic valve stenosis.
    Cramariuc D; Rogge BP; Lønnebakken MT; Boman K; Bahlmann E; Gohlke-Bärwolf C; Chambers JB; Pedersen TR; Gerdts E
    Heart; 2015 Feb; 101(3):209-14. PubMed ID: 25301859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.